EE701 Cost-Effectiveness Analysis of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in China
Abstract
Authors
X. Bai R. Shao B. Zhen Y. Xia X. He
X. Bai R. Shao B. Zhen Y. Xia X. He
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now